English
Choose your country/region and language
Your experience may change as only information for the country or region you select will be presented.
Advancements in diagnostics and therapeutics have healthcare providers in a constant quest to quickly spot, diagnose, and
monitor more conditions and populations than ever before. Enter highly-sensitive immunoassay testing.
A Growing Menu of Advanced Biomarkers
This increased demand and heightened expectations on diagnostics makes high-sensitivity immunoassay testing central to meeting the ever-changing needs of care delivery.
Discover diagnostic techniques and technologies designed to detect and measure very low concentrations of biomolecules with high accuracy and precision.
Sensitivity Detection Limits
Figure 1. Proven sensitivity of the DxI 9000 Immunoassay Analyzer
“At Beckman Coulter, we are committed to making rapid, accurate diagnostics more readily available to healthcare systems worldwide by developing new biomarkers in areas with significant unmet needs like Alzheimer’s disease.”
President, Beckman Coulter
Bringing Unparalleled Clinical Sensitivity to the Core Lab
We are revolutionizing the next generation in specialized diagnostics through high-sensitivity immunoassays, driving innovation,
advancing
medical insights, and enhancing diagnostic availability and adaptability to better serve patients across a variety of disease areas.
Products with Precision
A highly sensitive clinical analyzer, the DxI 9000 Immunoassay Analyzer is designed to power lab performance across health systems, delivering fast answers with precision and accuracy. Taking diagnostics to the next level, the DxI 9000 analyzer is equipped with industry-leading features like ZeroDaily Maintenance and Lumi-Phos PRO chemiluminescent substrate.
High throughput with high reliability
Learn more ›
Proven Diagnostic Sensitivity Across Disease Areas
Beckman Coulter and our proven high-sensitivity immunoassay capabilities found on the DxI 9000 Immunoassay Analyzer* are empowering labs and healthcare teams to address emerging diagnostic challenges across diverse areas, from cardiac to infectious diseases.
Cardiovascular Disease
A complete cardiac diagnostics menu to assess patients at risk for developing or experiencing cardiovascular disease.
Infectious Disease
Our infectious disease assays boost confidence in accurate reporting and timely disease management.
Women’s
Health
From fertility to menopause, highly-sensitive immunoassay testing for all stages of women’s health.
Educational Resources
Lumigen and the Lumigen product marks mentioned herein are trademarks or registered trademarks of Lumigen, Inc. in the United States and other countries. Lumigen is a Beckman Coulter company.
